메뉴 건너뛰기




Volumn 14, Issue 4, 2011, Pages 499-505

Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: Estimation for the Portuguese national health system

Author keywords

Breast cancer; Costs; Hospital; Prostate cancer; Skeletalrelated events

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

EID: 79959995003     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2010.11.014     Document Type: Article
Times cited : (32)

References (37)
  • 2
    • 2442595906 scopus 로고    scopus 로고
    • The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: Findings from a retrospective analysis of health plan data
    • DOI 10.1097/01.ju.0000127732.63726.4c
    • Penson DF, Moul JW, Evans CP, et al. The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data. J Urol, 2004;171(6 Pt 1):2250-4. (Pubitemid 38625445)
    • (2004) Journal of Urology , vol.171 , Issue.6 I , pp. 2250-2254
    • Penson, D.F.1    Moul, J.W.2    Evans, C.P.3    Doyle, J.J.4    Gandhi, S.5    Lamerato, L.6
  • 3
    • 3342971378 scopus 로고    scopus 로고
    • Cost of managing women presenting with stage IV breast cancer in the United Kingdom
    • DOI 10.1038/sj.bjc.6601890
    • Remak E, Brazil L. Cost of managing women presenting with stage IV breast cancer in the United Kingdom. Br J Cancer 2004;91:77-83. (Pubitemid 39013048)
    • (2004) British Journal of Cancer , vol.91 , Issue.1 , pp. 77-83
    • Remak, E.1    Brazil, L.2
  • 5
    • 85031214859 scopus 로고    scopus 로고
    • Direcção-Geral da Saúde, [Accessed August 27, 2009]
    • Direcção-Geral da Saúde. Risco de Morrer em Portugal 2005. Volume II. 2008. Available from: http://www.dgs.pt [Accessed August 27, 2009].
    • (2008) Risco de Morrer em Portugal 2005 , vol.2
  • 6
    • 0030749321 scopus 로고    scopus 로고
    • Skeletal complications of malignancy
    • Coleman RE. Skeletal complications of malignancy. Cancer 1997;80(8 Suppl):1588-94. (Pubitemid 27444031)
    • (1997) Cancer , vol.80 , Issue.8 SUPPL. , pp. 1588-1594
    • Coleman, R.E.1
  • 7
    • 3242772959 scopus 로고    scopus 로고
    • Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy
    • DOI 10.1002/cncr.20388
    • Krupski TL, Smith MR, Lee WC, et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 2004;101:541-9. (Pubitemid 38970605)
    • (2004) Cancer , vol.101 , Issue.3 , pp. 541-549
    • Krupski, T.L.1    Smith, M.R.2    Lee, W.C.3    Pashos, C.L.4    Brandman, J.5    Wang, Q.6    Botteman, M.7    Litwin, M.S.8
  • 8
    • 33746969954 scopus 로고    scopus 로고
    • Clinical management of women with metastatic breast cancer: A descriptive study according to age group
    • Manders K, van de Poll-Franse LV, Creemers GJ, et al. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer 2006;6:179.
    • (2006) BMC Cancer , vol.6 , pp. 179
    • Manders, K.1    Van De Poll-Franse, L.V.2    Creemers, G.J.3
  • 9
    • 18144427879 scopus 로고    scopus 로고
    • The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
    • DOI 10.1093/annonc/mdi122
    • Weinfurt KP, Li Y, Castel LD, et al. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol 2005;16:579-84. (Pubitemid 40613323)
    • (2005) Annals of Oncology , vol.16 , Issue.4 , pp. 579-584
    • Weinfurt, K.P.1    Li, Y.2    Castel, L.D.3    Saad, F.4    Timbie, J.W.5    Glendenning, G.A.6    Schulman, K.A.7
  • 10
    • 35048875471 scopus 로고    scopus 로고
    • Pathologic fractures correlate with reduced survival in patients with malignant bone disease
    • DOI 10.1002/cncr.22991
    • Saad F, Lipton A, Cook R, et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 2007;110:1860-7. (Pubitemid 47557312)
    • (2007) Cancer , vol.110 , Issue.8 , pp. 1860-1867
    • Saad, F.1    Lipton, A.2    Cook, R.3    Chen, Y.-M.4    Smith, M.5    Coleman, R.6
  • 11
    • 34548584066 scopus 로고    scopus 로고
    • Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer
    • DOI 10.1007/s00520-006-0203-x
    • DePuy V, Anstrom KJ, Castel LD, et al. Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 2007;15:869-76. (Pubitemid 47387507)
    • (2007) Supportive Care in Cancer , vol.15 , Issue.7 , pp. 869-876
    • DePuy, V.1    Anstrom, K.J.2    Castel, L.D.3    Schulman, K.A.4    Weinfurt, K.P.5    Saad, F.6
  • 12
    • 36649001116 scopus 로고    scopus 로고
    • Bisphosphonates: Reducing the risk of skeletal complications from bone metastasis
    • Costa L. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis. Breast 2007;16(Suppl. 3):S16 -20.
    • (2007) Breast , vol.16 , Issue.SUPPL. 3
    • Costa, L.1
  • 14
    • 0242669907 scopus 로고    scopus 로고
    • Costs of prostate cancer, metastatic to the bone, in The Netherlands
    • DOI 10.1016/S0302-2838(03)00007-1
    • Groot MT, Boeken Kruger CG, Pelger RC, Uyl-de Groot CA. Costs of prostate cancer, metastatic to the bone, in the Netherlands. Eur Urol 2003;43:226-32. (Pubitemid 36314233)
    • (2003) European Urology , vol.43 , Issue.3 , pp. 226-232
    • Groot, M.T.1    Kruger, C.G.G.B.2    Pelger, R.C.M.3    Uyl-de Groot, C.A.4
  • 15
    • 33748871114 scopus 로고    scopus 로고
    • Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice
    • Delea T, McKiernan J, Brandman J, et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol 2006;4:341-7. (Pubitemid 44420137)
    • (2006) Journal of Supportive Oncology , vol.4 , Issue.7 , pp. 341-347
    • Delea, T.1    McKiernan, J.2    Brandman, J.3    Edelsberg, J.4    Sung, J.5    Raut, M.6    Oster, G.7
  • 16
    • 43949146650 scopus 로고    scopus 로고
    • The cost of treating skeletalrelated events in patients with prostate cancer
    • Lage MJ, Barber BL, Harrison DJ, Jun S. The cost of treating skeletalrelated events in patients with prostate cancer. Am J Manag Care 2008; 14:317-22.
    • (2008) Am J Manag Care , vol.14 , pp. 317-322
    • Lage, M.J.1    Barber, B.L.2    Harrison, D.J.3    Jun, S.4
  • 17
    • 1442351128 scopus 로고    scopus 로고
    • A systematic review of the role of bisphosphonates in metastatic disease
    • Ross JR, Saunders Y, Edmonds PM, Patel S, et al. A systematic review of the role of bisphosphonates in metastatic disease. Health Technol Assess 2004;8:1-176.
    • (2004) Health Technol Assess , vol.8 , pp. 1-176
    • Ross, J.R.1    Saunders, Y.2    Edmonds, P.M.3    Patel, S.4
  • 18
    • 85031232477 scopus 로고    scopus 로고
    • Ministério da Saúde and Instituto de Gestão Informática e Financeira da Saúde, [Accessed March 22 2010]
    • Ministério da Saúde and Instituto de Gestão Informática e Financeira da Saúde. Estatísticas do movimento assistencial 2002-2005. Available from: www.igif.min-saude.pt [Accessed March 22, 2010].
    • Estatísticas do movimento assistencial 2002-2005
  • 19
    • 85031220639 scopus 로고    scopus 로고
    • Ministério da Saúde. Portaria no132/2003 de 5 de Fevereiro. Diário da República I série B. 2003
    • Ministério da Saúde. Portaria no132/2003 de 5 de Fevereiro. Diário da República I série B. 2003.
  • 21
    • 5344244656 scopus 로고    scopus 로고
    • R Development Core Team. R Foundation for Statistical Computing Vienna Austria, [Accessed March 22 2010]
    • R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2008 Available from: http://www.R-project.org [Accessed March 22, 2010].
    • (2008) R: A Language and Environment for Statistical Computing
  • 22
    • 0034008718 scopus 로고    scopus 로고
    • Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate
    • Gessner U, Koeberle D, Thuerlimann B, et al. Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate. Support Care Cancer 2000;8:115-22. (Pubitemid 30114819)
    • (2000) Supportive Care in Cancer , vol.8 , Issue.2 , pp. 115-122
    • Gessner, U.1    Koeberle, D.2    Thuerlimann, B.3    Bacchus, L.4    Horisberger, B.5
  • 23
    • 53149089426 scopus 로고    scopus 로고
    • Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: Analysis of a national medical claims database
    • Hatoum HT, Lin SJ, Smith MR, et al. Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database. Cancer 2008;113:1438-45.
    • (2008) Cancer , vol.113 , pp. 1438-1445
    • Hatoum, H.T.1    Lin, S.J.2    Smith, M.R.3
  • 24
    • 10744233021 scopus 로고    scopus 로고
    • Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: A randomized, double-blind, multicenter, comparative trial
    • DOI 10.1002/cncr.11701
    • Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 2003;98:1735-44. (Pubitemid 37238631)
    • (2003) Cancer , vol.98 , Issue.8 , pp. 1735-1744
    • Rosen, L.S.1    Gordon, D.2    Kaminski, M.3    Howell, A.4    Belch, A.5    Mackey, J.6    Apffelstaedt, J.7    Hussein, M.A.8    Coleman, R.E.9    Reitsma, D.J.10    Chen, B.-L.11    Seaman, J.J.12
  • 26
    • 18844440666 scopus 로고    scopus 로고
    • Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK
    • DOI 10.1185/030079905X40472
    • Guest JF, Clegg JP, Davie AM, McCloskey E. Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK. Curr Med Res Opin 2005;21:805-15. (Pubitemid 40695303)
    • (2005) Current Medical Research and Opinion , vol.21 , Issue.5 , pp. 805-815
    • Guest, J.F.1    Clegg, J.P.2    Davie, A.M.3    McCloskey, E.4
  • 27
    • 66949136282 scopus 로고    scopus 로고
    • Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials
    • Machado M, Cruz LS, Tannus G, Fonseca M. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials. Clin Ther 2009;31:962-79.
    • (2009) Clin Ther , vol.31 , pp. 962-979
    • Machado, M.1    Cruz, L.S.2    Tannus, G.3    Fonseca, M.4
  • 28
    • 45149127283 scopus 로고    scopus 로고
    • Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients
    • Paterson A, McCloskey E, Redzepovic J, Ott I, Gust R. Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients. J Int Med Res 2008; 36:400-13. (Pubitemid 351833589)
    • (2008) Journal of International Medical Research , vol.36 , Issue.3 , pp. 400-413
    • Paterson, A.H.G.1    McCloskey, E.2    Redzepovic, J.3    Ott, I.4    Gust, R.5
  • 30
    • 36549012194 scopus 로고    scopus 로고
    • Higher persistency with i.v. bisphosphonates in patients with bone metastasis
    • abstract 18623
    • Mangiapane S, Hoer A, Gothe H, et al. Higher persistency with i.v. bisphosphonates in patients with bone metastasis. J Clin Oncol 2006; 24(18 Suppl.):698s [abstract 18623].
    • (2006) J Clin Oncol , vol.24 , Issue.18 SUPPL.
    • Mangiapane, S.1    Hoer, A.2    Gothe, H.3
  • 31
    • 0344309882 scopus 로고    scopus 로고
    • Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: Analysis of routine data
    • Ham C, York N, Sutch S, Shaw R. Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data. BMJ 2003;327:1257.
    • (2003) BMJ , vol.327 , pp. 1257
    • Ham, C.1    York, N.2    Sutch, S.3    Shaw, R.4
  • 32
    • 37249057002 scopus 로고    scopus 로고
    • Trends in hospital bed utilisation in New Zealand 1989 to 2006: More or less beds in the future?
    • Malcolm L. Trends in hospital bed utilisation in New Zealand 1989 to 2006: more or less beds in the future? N Z Med J 2007;120:U2772.
    • (2007) N Z Med J , vol.120
    • Malcolm, L.1
  • 33
    • 1642571450 scopus 로고    scopus 로고
    • Organization for Economic Co-operation and Development, [Accessed June 18, 2009]
    • Organization for Economic Co-operation and Development. Health at a glance 2007: OECD indicators. Available from: http://www.oecd.org [Accessed June 18, 2009].
    • Health at A Glance 2007: OECD Indicators
  • 34
    • 0036676214 scopus 로고    scopus 로고
    • Estimating health care costs related to cancer treatment from SEER-Medicare data
    • Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002;40(8 Suppl):IV-104-17.
    • (2002) Med Care , vol.40 , Issue.8 SUPPL.
    • Brown, M.L.1    Riley, G.F.2    Schussler, N.3    Etzioni, R.4
  • 35
    • 1542723219 scopus 로고    scopus 로고
    • A longitudinal study of the effects of age and time to death on hospital costs
    • DOI 10.1016/j.jhealeco.2003.08.004, PII S0167629603000857
    • Seshamani M, Gray AM. A longitudinal study of the effects of age an time to death on hospital costs. J Health Econ 2004;23:217-35. (Pubitemid 38333024)
    • (2004) Journal of Health Economics , vol.23 , Issue.2 , pp. 217-235
    • Seshamani, M.1    Gray, A.M.2
  • 36
    • 33746853119 scopus 로고    scopus 로고
    • Health care costs in the last year of life-The Dutch experience
    • DOI 10.1016/j.socscimed.2006.04.018, PII S0277953606002279
    • Polder JJ, Barendregt JJ, van Oers V. Health care costs in the last year of life - the Dutch experience. Soc Sci Med 2006;63:1720-31. (Pubitemid 44176177)
    • (2006) Social Science and Medicine , vol.63 , Issue.7 , pp. 1720-1731
    • Polder, J.J.1    Barendregt, J.J.2    Van Oers, H.3
  • 37
    • 0030919507 scopus 로고    scopus 로고
    • Economic foundations of cost-effectiveness analysis
    • DOI 10.1016/S0167-6296(96)00506-1, PII S0167629696005061
    • Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ 1997;16:1-31. (Pubitemid 27224092)
    • (1997) Journal of Health Economics , vol.16 , Issue.1 , pp. 1-31
    • Garber, A.M.1    Phelps, C.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.